Skip to main content
TipRanks
Go Ultimate75% OFF

Jazz Pharmaceuticals (J7Z) Ownership - Who Owns Jazz Pharmaceuticals?

0 Followers

Jazz Pharmaceuticals (J7Z) Ownership Overview

  • 3.37% Insiders
  • 32.65% Mutual Funds
  • 34.83% Other Institutional Investors
  • 28.08% ETFs
  • 1.06% Public Companies and Individual Investors

The ownership structure of Jazz Pharmaceuticals (CH:J7Z) stock is a mix of institutional, retail, and individual investors. Approximately 95.57% of the company’s stock is owned by Institutional Investors, 3.37% is owned by Insiders, and 1.06% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 05, 2026Patricia Carr$326,910
May 31, 2026Samantha Pearce$1,625,977
May 26, 2026Rick Winningham$662,143
May 26, 2026Heather Ann Mcsharry$482,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Goalvest Advisory LlcCHF51,000
Dec 31, 2025Platinum Investment ManagementCHF76,840
Dec 31, 2025Graham Capital Management, L.p.CHF206,380
Dec 31, 2025Innealta Capital, LlcCHF235,620

Top Shareholders

CH:J7Z top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.6,454,463Institution10.06%―
Ishares6,067,871Institution9.45%―
Vanguard5,095,410Institution7.94%―
Vanguard Index Funds4,844,437Institution7.55%―
American Funds Fundamental Investors2,100,000Institution3.27%―
Capitol Series Trust1,561,563Institution2.43%―
Spdr1,394,229Institution2.17%―
Seamus Mulligan1,286,254Insider2.00%―
Fidelity Select Portfolios1,085,952Institution1.69%―
Dfa975,269Institution1.52%―

Top Mutual Fund Holders

CH:J7Z top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds4,844,437Institution7.55%―
American Funds Fundamental Investors2,100,000Institution3.27%―
Capitol Series Trust1,561,563Institution2.43%―
Fidelity Select Portfolios1,085,952Institution1.69%―
Fidelity Puritan Trust855,427Institution1.33%―
Fidelity Rutland Square Trust Ii789,002Institution1.23%―
Fidelity Concord Street Trust748,648Institution1.17%―
Dfa Investment Dimensions Group Inc677,608Institution1.06%―
Franklin Strategic Series596,738Institution0.93%―
Fidelity Salem Street Trust545,798Institution0.85%―

FAQ

Who Owns Jazz Pharmaceuticals (CH:J7Z)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 95.57% of the company's stock is held by institutional investors, 3.37% is held by insiders, and 1.06% is held by public companies and individual investors.
What percentage of Jazz Pharmaceuticals (CH:J7Z) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 95.57% of Jazz Pharmaceuticals (CH:J7Z) stock is held by institutional investors: 32.65% by mutual funds, 28.08% by ETFs and 34.83% by other institutional investors.
What percentage of Jazz Pharmaceuticals (CH:J7Z) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 1.06% of Jazz Pharmaceuticals (CH:J7Z) stock is held by public companies and individual investors.
Who owns the most shares of Jazz Pharmaceuticals (CH:J7Z)?
BlackRock, Inc. owns the most shares of Jazz Pharmaceuticals (CH:J7Z).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.